Clinical trial
Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor
NCT00102674 · The Medicines Company, Industry · Completed
Key facts
| NCT number | NCT00102674 |
|---|---|
| Title | Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor |
| Official title | The Pharmacokinetics and Pharmacodynamics of a Cangrelor Bolus Plus Infusion in Healthy Volunteers |
| Lead sponsor | The Medicines Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | cangrelor |
| Enrollment | 40 |
| Start date | Mar 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Feb 1, 2005 |
| Last update posted | Aug 16, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: